(NasdaqGM:NTLA), CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on August 1, 2025, it awarded an inducement grant to five new employees under Intellia's 2024 Inducement Plan as a material inducement to employment. The inducement […]
(TSX:APS),(Pinksheets:APTOF),(PinkSheets:APTOF), SAN DIEGO and TORONTO, Aug. 01, 2025 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC: APTOF; OTCQB: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat patients with newly diagnosed acute myeloid leukemia (AML), announced today that the Company's Board of
(NasdaqGM:NEXN), NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced that during July 2025 the Company repurchased 880,000 Ordinary Shares at an average price of $10.41. As of July 31, 2025,
Berkshire Hills Bancorp, Inc. (NYSE: BHLB) today announced that its Board of Directors has approved a quarterly cash dividend of $0.18 per common share to shareholders of record at the close of business on August 14, 2025, payable on August 21, 2025. https://mma.prnewswire.com/media/1626839/BHLB_Logo1.jpg About Berkshire Hills Bancorp Berkshire Hills Bancorp, Inc. (NYSE: BHLB) is the
Second Quarter Highlights* — Diluted EPS for the Quarter of $2.23, Up 68 percent, primarily due to the non-recurring 2024 impairment of intangible assets recognized in the Digital reporting unit — Adjusted Diluted EPS(1) for the Quarter of $2.46, Up 14 percent — Record Net Revenue for the Quarter of $587.3 million, Up 14 percent
Today, Aegis Brands Inc. (TSX: AEG) reports financial results for the second quarter ending June 29th, 2025. Highlights for the quarter: — System sales decreased by 4.2% to $35.2 million and same store sales decreased by 7.5%. — Adjusted EBITDA for the second quarter was consistent with the prior year at $1.6 million. — Net
Astute Connect: The Expert Network industry to Reach US$ 5.5 Billion by 2030 Business in today's fast-paced and knowledge-driven world is constantly under pressure to innovate, adapt, and make informed decisions quickly to maintain its competitive edge. Expertise is more important than ever, as specialized knowledge affects business success, problem-solving, and strategic planning. GlobeNewswire August
NeuroPace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy with Neurostimulator Cases GlobeNewswire August 01, 2025 MOUNTAIN VIEW, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) — NeuroPace, Inc. (Nasdaq: NPCE), a medical technology company focused on transforming the lives of people living with epilepsy, today issued the following statement in response to the Centers for
Abeona Therapeutics(R) Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire August 01, 2025 CLEVELAND, Aug. 01, 2025 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
Aptose Selects Ernst & Young Global Limited as its New Independent Auditor and Calls Reconvened Meeting of its Shareholders Aptose to hold a reconvened shareholder meeting on August 22, 2025 at 10:00 a.m. (Eastern Time) to vote on appointment of new auditor GlobeNewswire August 01, 2025 SAN DIEGO and TORONTO, Aug. 01, 2025 (GLOBE NEWSWIRE)